title: [Prophylactic treatment of preeclampsia].
abstract: The pathophysiology of preeclampsia is still unknown. Low-dose aspirin showed a reduction of the preeclampsia rate in a high-risk situation.There is a lack of prospective randomized studies to prove the benefit of heparin treatment in patients with hereditary thrombophilia. Different prophylactic therapies did not show any benefit in the prevention of preeclampsia in clinical studies.
authors.affiliation: Universitätsfrauenklinik Tübingen, Tübingen, Deutschland.
authors.forename: B
authors.initials: B
authors.lastname: Schauf
authors.forename: M K
authors.initials: MK
authors.lastname: Bohlmann
authors.forename: D
authors.initials: D
authors.lastname: Wallwiener
authors.forename: H
authors.initials: H
authors.lastname: Abele
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage*; D002986:Clinical Trials as Topic / Q000639:trends; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D005858:Germany; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000639:trends; D011225:Pre-Eclampsia / Q000188:drug therapy* / Q000517:prevention & control*; D011247:Pregnancy
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D001241:Aspirin